Novartis has challenged section 3(d) of the Indian Patents Act in Supreme Court. Amit Sengupta speaks to Newsclick about the ramifications in case Novartis' challenge is upheld.
Novartis has challenged section 3(d) of the Indian Patents Act in Supreme Court. Amit Sengupta speaks to Newsclick about the ramifications in case Novartis' challenge is upheld.